Profil
Bernard Reculeau served as Chairman at CIS Bio International SA. He was a Director at Theratechnologies, Inc. from 2005 to 2011.
From 2010 to 2014, he served as Director at Neurokin SA. He was a Member-Management Team at Ion Beam Applications SA. He also served as Senior Vice President at Aventis, Inc. Mr. Reculeau was President at Cisbio Bioassays SAS in 2009.
He was a General Manager at Rhone-Poulenc Rorer, Inc. and Senior Vice President & General Manager at Rhone-Poulenc Rorer SA. Mr. Reculeau received his undergraduate degree from Sciences Po in 1974 and from Ecole Nationale d'Administration in 1977.
Anciens postes connus de Bernard Reculeau
| Sociétés | Poste | Fin |
|---|---|---|
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy | Directeur/Membre du Conseil | 11/03/2014 |
Cisbio Bioassays SAS
Cisbio Bioassays SAS Medical SpecialtiesHealth Technology Develops immunoassays | President | 01/01/2009 |
Rhone-Poulenc Rorer SA | Corporate Officer/Principal | - |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Corporate Officer/Principal | - |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
Formation de Bernard Reculeau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Cisbio Bioassays SAS
Cisbio Bioassays SAS Medical SpecialtiesHealth Technology Develops immunoassays | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
CIS Bio International SA
CIS Bio International SA Pharmaceuticals: MajorHealth Technology Develops, produces, markets and distributes radiopharmaceuticals for diagnosis & therapy | Health Technology |
Sciences Po
Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ecole Nationale d'Administration
Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy | Health Technology |
Rhone-Poulenc Rorer SA |
















